Latest Posts:

Sorry, no posts matched your criteria.

Follow Us:

Back To Top

Head of Strategic Partnerships in Therapeutics

Building “optimised ventures” in curative therapeutics, with a focus on Business Development and Portfolio Management

Full time, starting asap, remotely (at least initially)

About the role

As we are rapidly expanding venture building across sectors, we’re looking for an experienced business development professional to join us and support the growth of the Therapeutics sector at DSV.

You will be working together in close partnership with the Associate Director for Therapeutics and the rest of the exec team to build strategic alliances, fundraise and grow our portfolio of new ventures.

The role is very dynamic, juggling multiple portfolios of work and owning the outcomes. We’re after someone who’d want to build and grow the company alongside the current team, making valuable contributions not only to the therapeutics side of the business, but the organisation as a whole.

 

Key responsibilities:

●  Sourcing and building strategic partnerships with big pharma, foundations and charities looking for alternative approach to innovation in areas such as oncology, cardiovascular and neurodegenerative diseases etc.;

●  Building founding teams with deep technical expertise in their area and helping them to drive innovative concepts from idea to company formation;

● Mentoring Founders across our therapeutics portfolio to support them with commercial strategy, fundraising, strategic partnerships and other on tap support.

Our therapeutics portfolio

Ventures you’ll be supporting

Current Founders (pre-Company)

Founders working in therapeutics (oncology)

Chris: background in Drug Discovery and Biotech, working on educating the immune system to recognise and eliminate solid tumours through the use of oncolytic viruses or gene delivery using other vectors. Solid tumours are incalcitrant to traditional therapies due to suppression of the immune system.. This is where I’m hoping to make an impact – to design biological drugs that stimulate the immune system to recognise tumour tissue as a foe and eliminate this from the body.

Pedro: background in Oncology and Cancer Biology, working on building new therapeutic strategies in the solid tumor microenvironment. The microenvironment is a complex intricate system os different cellular and acellular components which all work together to allow cancer to grow. Being genetically stable, targeting these components has a lot of potential to have significant impact in the fight against cancer.

Andreas: background in Drug Discovery, Diagnostics and Pharma Corporate BD, working on leveraging synthetic lethality and the clonal architecture of tumour evolution to develop effective cancer therapies. By using large scale gene perturbation studies and integrating genome evolution and gene interaction data, we discover previously unknown targets that can achieve more efficient and lasting responses in patients and address major problems in cancer therapy, such as tumour heterogeneity.

Chris: background in Drug Discovery and Biotech, working on educating the immune system to recognise and eliminate solid tumours through the use of oncolytic viruses or gene delivery using other vectors. Solid tumours are incalcitrant to traditional therapies due to suppression of the immune system.. This is where I’m hoping to make an impact – to design biological drugs that stimulate the immune system to recognise tumour tissue as a foe and eliminate this from the body.

Pedro: background in Oncology and Cancer Biology, working on building new therapeutic strategies in the solid tumor microenvironment. The microenvironment is a complex intricate system os different cellular and acellular components which all work together to allow cancer to grow. Being genetically stable, targeting these components has a lot of potential to have significant impact in the fight against cancer.

Andreas: background in Drug Discovery, Diagnostics and Pharma Corporate BD, working on leveraging synthetic lethality and the clonal architecture of tumour evolution to develop effective cancer therapies. By using large scale gene perturbation studies and integrating genome evolution and gene interaction data, we discover previously unknown targets that can achieve more efficient and lasting responses in patients and address major problems in cancer therapy, such as tumour heterogeneity.

About you

The role requires sufficient breadth and depth of insight across therapeutics-related fields both in terms of the science and industry dynamics. Background in a science related field is a must, having demonstrated practical, hands on research or product development work. Most recent focus, however, should be on commercial roles, demonstrating aptitude for value creation and getting deals done.

 

Key required attributes:

●  Excellent interpersonal and verbal communication skills with the ability to lead conversations across both technical and commercial domains;

●  Demonstrated interest in innovation, advancing new concepts and ideas – enjoys highly creative work environment;

●  Technical depth acquired through a PhD/Research/Fellow or product development type of roles or responsibilities;

●  Broad interests and views across different therapeutics areas with intimate knowledge of industry-specific macro and micro dynamics;

●  Intimate understanding of the early-stage commercialisation process acquired through previous exposure to the startup/VC/CVC/TTO etc. environment;

●  Network-driven, enjoys supporting and guiding others through collaborative teamwork.

 

Likely to have held one of more of the following roles/titles in the past: Head of Strategic Partnerships, Head of Business Development, Business Development Director, Director of business development, Partnerships Manager, etc.

About us

We work across sectors from oncology to energy storage across the stack from cutting edge technology to fortune 100 partnerships (some have not been announced yet) and have built nearly 30 companies over the last three years. 

You’ll be part of a small adventurous exec team though with huge growth ambitions, driven by the desire to make a massive positive impact on the world.

We offer an equity stake in the company along with generous BD incentives and a base salary.

 

 

Contact

For further info and to discuss the role, please submit an expression of interest.